Tempus AI (MIL:1TEM) 3-Year RORE % : -18.98% (As of Mar. 2026)


MIL:1TEM Tempus AI Inc MIL:1TEM
33 GF Score
Price €53.53
! 3 Warning Signs
View Full Analysis

What is Tempus AI 3-Year RORE %?

Tempus AI MIL:1TEM +3.70% 33 3-Year RORE % is -18.98 as of Mar. 2026. GuruFocus rates MIL:1TEM with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Tempus AI ranks worse than 65.29% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Tempus AI's 3-Year RORE % for the quarter that ended in Mar. 2026 was -18.98%.

The industry rank for Tempus AI's 3-Year RORE % or its related term are showing as below:

MIL:1TEM's 3-Year RORE % is ranked worse than
65.29% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: -0.32 vs MIL:1TEM: -18.98

Tempus AI  (MIL:1TEM) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Tempus AI 3-Year RORE % Related Terms


Tempus AI 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Tempus AI's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tempus AI 3-Year RORE % Chart

Tempus AI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial 0.00 0.00 9.34 46.96 -12.95

Tempus AI Quarterly Data
Sep20 Dec20 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.59 -19.44 -26.90 -12.95 -18.98

MIL:1TEM vs HQY, BTSG, HNGE: 3-Year RORE % Comparison

For the Health Information Services subindustry, Tempus AI's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tempus AI 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tempus AI's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Tempus AI's 3-Year RORE % falls into.


MIL:1TEM
33GF Score
Tempus AI Inc MIL:1TEM
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tempus AI 3-Year RORE % Calculation

Tempus AI's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -1.488--3.68 )/( -11.551-0 )
=2.192/-11.551
=-18.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -18.98 mean?
Tempus AI (MIL:1TEM) has a 3-Year RORE % of -18.98 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tempus AI and its competitors. According to the industry distribution chart, Tempus AI ranks #395 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 65.3%.
Is Tempus AI's 3-Year RORE % too high?
Tempus AI's current 3-Year RORE % is -18.98. Based on the distribution chart, Tempus AI ranks #395 out of 605 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tempus AI has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Tempus AI's 3-Year RORE % compare to HQY and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Tempus AI ranks #395 out of 605 companies for 3-Year RORE %. This places Tempus AI in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Tempus AI and its competitors. Tempus AI's current 3-Year RORE % is -18.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tempus AI stock overvalued right now?
Tempus AI (MIL:1TEM) has a current 3-Year RORE % of -18.98. The current 3-Year RORE % is -18.98. Tempus AI's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Tempus AI (MIL:1TEM), the current 3-Year RORE % is -18.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tempus AI Business Description

Other Exchanges TEM:USAF3M:Germany
Address 600 West Chicago Avenue, Suite 510, Chicago, IL, USA, 60654
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
33GF Score

Get the complete analysis for MIL:1TEM

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€53.53
Price